Jul 30, 2019 / 11:15PM GMT
Operator
Thank you for standing by, and welcome to the ImpediMed Q4 FY 2019 Investor Conference Call. (Operator Instructions)
I would now like to hand the conference over to Mr. Richard Carreon, Managing Director and CEO. Please go ahead.
Richard Carreon - ImpediMed Limited - MD, CEO, President & Executive Director
Thank you, Lexie. Welcome, and thank you for joining us today. We are hosting this conference call to discuss our 4C for the fourth fiscal year quarter ending 30 June 2019. Our CFO, Morten Vigeland, is with me on the line as well.
During today's call, I'll be referencing the 4C we lodged this morning, Australian time, as well as the investor slide presentation lodged the 19th of June. As you know, we were just in the market last month, so our comments will focus on just the key issues. As we normally do, we'll take questions following my comments.
Our financial results for the quarter ending 30 June were as follows. Total revenue for the quarter was up 40% to $1.4 million, up from $1.0 million last quarter. This growth was
Q4 2019 ImpediMed Ltd Earnings Call Transcript
Jul 31, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers